Gábor Holló and Andreas Katsanos
220
[45] Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in
untreated exfoliation and primary open-angle glaucoma. Arch.
Ophthalmol. 1997; 115: 182-5.
[46] Quaranta L, Katsanos A, Russo A, Riva I. 24-hour intraocular pressure
and ocular perfusion pressure in glaucoma. Surv. Ophthalmol. 2013; 58:
26 - 41.
[47] Schlötzer-Schrehardt U, Naumann GOH. Pseudoexfoliation glaucoma.
In: Grehn F, Stamper R, editors. Glaucoma. Berlin: Springer; 2004; 157-
76.
[48] Konstas AGP, Tsironi S, Kozobolis VP. Medical therapy of exfoliative
glaucoma. In: Holló G, Konstas AGP, editors. Exfoliation syndrome and
exfoliative glaucoma (3rd edition). Savona: PubliComm; 2015; 171-80.
[49] Konstas AG, Katsanos A, Quaranta L, Mikropoulos DG, Tranos PG,
Teus MA. Twenty-four hour efficacy of glaucoma medications. Prog.
Brain Res. 2015; 221: 297-318.
[50] Ebstein RP, Stessman J, Eliakim R, Menczel J. The effect of age on
beta-adrenergic function in man: a review. Isr. J. Med. Sci. 1985; 21:
302 - 11.
[51] Nieminen T, Uusitalo H, Mäenpää J, Turjanmaa V, Rane A, Lundgren S,
Ropo A, Rontu R, Lehtimäki T, Kähönen M. Polymorphisms of genes
CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic
effects of ophthalmic timolol. A pilot study. Eur. J. Clin. Pharmacol.
2005; 61:811-9.
[52] Quaranta L, Biagioli E, Riva I, Rulli E, Poli D, Katsanos A, Floriani I.
Prostaglandin analogs and timolol-fixed versus unfixed combinations or
monotherapy for open-angle glaucoma: a systematic review and meta-
analysis. J. Ocul. Pharmacol. Ther. 2013; 29: 382-9.
[53] Konstas AG, Mylopoulos N, Karabatsas CH, Kozobolis VP, Diafas S,
Papapanos P, Georgiadis N, Stewart WC. Diurnal intraocular pressure
reduction with latanoprost 0.005% compared to timolol maleate 0.5% as
monotherapy in subjects with exfoliation glaucoma. Eye 2004;18:893-9.
[54] Parmaksiz S, Yüksel N, Karabas VL, Ozkan B, Demirci G, Caglar Y. A
comparison of travoprost, latanoprost, and the fixed combination of
dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
Eur. J. Ophthalmol. 2006; 16: 73-80.
[55] Konstas AGP, Kozobolis VP, Katsimpris IE et al. Efficacy and safety of
latanoprost versus travoprost in exfoliative glaucoma patients.
Ophthalmology 2007; 114: 653-7.